ACADIA Pharmaceuticals Inc Cash Flow Reinvestment Rate
ACADIA Pharmaceuticals Inc cash flow reinvestment rate. ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Reinvestment Rate of 0.10x as of June 2026, reinvesting $13.74 Million (capex $10.30 Million plus investments $-3.44 Million) from operating cash flow of $134.76 Million. Explore ACADIA Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ACADIA Pharmaceuticals Inc (2023–2025)
Cash flow reinvestment rate of ACADIA Pharmaceuticals Inc from 2023 to 2025. Historical reinvestment intensity for ACADIA Pharmaceuticals Inc across 3 annual periods. Explore ACAD capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
ACADIA Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2023–2025)
ACADIA Pharmaceuticals Inc cash flow reinvestment rate by year from 2023 to 2025. Year-by-year capital reinvestment analysis for ACADIA Pharmaceuticals Inc. For the full cash flow conversion analysis, see ACADIA Pharmaceuticals Inc (ACAD) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.85x | $203.73 Million | $109.84 Million | $4.69 Million | ▲ +841.8% |
| 2024 | 0.20x | $31.06 Million | $157.72 Million | $523.00K | ▼ -95.4% |
| 2023 | 4.31x | $72.05 Million | $16.70 Million | $40.05 Million | — |